Characteristics of herpes zoster-associated hospitalizations in Madrid (SPAIN) before vaccine availability

被引:9
|
作者
Esteban-Vasallo, Maria D. [1 ]
Felicitas Dominguez-Berjon, M. [1 ]
Gil de Miguel, Angel [2 ]
Astray-Mochales, Jenaro [1 ]
Blanco-Ancos, Luis M. [1 ]
Gil-Prieto, Ruth [2 ]
机构
[1] Madrid Reg Hlth Author, Subdirectorate Hlth Promot & Prevent, C San Martin de Porres 6, Madrid 28035, Spain
[2] Rey Juan Carlos Univ, Area Prevent Med & Publ Hlth, Madrid 28922, Spain
关键词
Chronic conditions; Comorbidity; Epidemiology; Herpes zoster; Hospitalization; Immunosuppression; Incidence; CHRONIC MEDICAL CONDITIONS; POSTHERPETIC NEURALGIA; RISK-FACTORS; VARICELLA; EPIDEMIOLOGY; BURDEN; IMPACT; INFECTION; DECLINE; EUROPE;
D O I
10.1016/j.jinf.2015.10.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: This study aimed to estimate the frequency of hospitalizations due to herpes zoster (HZ) and to describe their clinical characteristics by sex and age group. Methods: Descriptive population-based cross-sectional study of hospital admissions due to HZ from 2003 to 2013 among residents in the Autonomous Community of Madrid. Sex, age, comorbidities, length of stay and outcomes were collected and described. Crude and age-adjusted cumulative incidence rates, and stratified by sex and age, were estimated. Robust Poisson regression analysis was used to calculate the incidence rate ratios by age group. Results: 2039 hospitalizations were identified (51.0% in women). Complicated HZ caused 48.7% of them (50.9% in women). The hospitalization rate was 2.98/100,000 person-years and 7.19/1000 cases of HZ in primary care. Both rates were significantly higher in men, except in the extreme age groups. An immunosuppression-associated comorbidity was identified in 32.8% of the cases and was less common in patients >= 75 years of age. The median length of stay was 6 days, and in-hospital mortality was 1.4%. Conclusions: Hospitalization rates due to HZ were higher in men and increased with age. In two out of every three cases, a comorbidity that potentially caused immunosuppression could not be identified. These cases could benefit from vaccination. (C) 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:70 / 79
页数:10
相关论文
共 50 条
  • [21] Herpes zoster-associated trigeminal trophic syndrome: a case report and review
    Litschel, R
    Winkler, H
    Dazert, S
    Sudhoff, H
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2003, 260 (02) : 86 - 90
  • [22] Vaccine-Associated Herpes Zoster
    Kim, Mary
    Juern, Anna M.
    Paley, Sharyl
    Chiu, Yvonne E.
    JOURNAL OF PEDIATRICS, 2015, 167 (02): : 494 - 494
  • [23] Later onset of herpes zoster-associated immune reconstitution inflammatory syndrome
    Espinosa, E.
    Pena-Jimenez, A.
    Ormsby, C. E.
    Vega-Barrientos, R.
    Reyes-Teran, G.
    HIV MEDICINE, 2009, 10 (07) : 454 - 457
  • [24] A specific thrombin inhibitor, argatroban, alleviates herpes zoster-associated pain
    Fujii, K
    Kanno, Y
    Konishi, K
    Ohgou, N
    JOURNAL OF DERMATOLOGY, 2001, 28 (04): : 200 - 207
  • [25] Herpes zoster-associated trigeminal trophic syndrome: a case report and review
    R. Litschel
    H. Winkler
    S. Dazert
    H. Sudhoff
    European Archives of Oto-Rhino-Laryngology, 2003, 260 : 86 - 90
  • [26] The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster
    Kurokawa, I.
    Murakawa, K.
    Kumano, K.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (07) : 1223 - 1229
  • [27] HERPES ZOSTER-ASSOCIATED RESOURCES CONSUMPTION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS
    Munoz-Quiles, C.
    Lopez-Lacort, M.
    Diez-Domingo, J.
    VALUE IN HEALTH, 2016, 19 (07) : A603 - A604
  • [28] Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials
    Kim, Joon Hyung
    Johnson, Robert
    Kovac, Martina
    Cunningham, Anthony L.
    Amakrane, Mohamed
    Sullivan, Keith M.
    Dagnew, Alemnew F.
    Curran, Desmond
    Schuind, Anne
    PAIN, 2023, 164 (04) : 741 - 748
  • [29] HERPES ZOSTER-ASSOCIATED ENCEPHALITIS - CLINICOPATHOLOGIC REPORT OF 12 CASES AND REVIEW OF THE LITERATURE
    JEMSEK, J
    GREENBERG, SB
    TABER, L
    HARVEY, D
    GERSHON, A
    COUCH, RB
    MEDICINE, 1983, 62 (02) : 81 - 97
  • [30] Cell-mediated immune (CMI) responses and zoster-associated pain in herpes zoster (HZ) patients
    Tyring, S.
    Levin, M.
    Xu, J.
    Wang, W.
    Keller, P.
    Smith, J.
    Caulfield, M.
    Barben, J.
    Stek, J.
    Vessey, R.
    Senior, S.
    Schodel, F.
    Chan, I.
    Schlienger, K.
    Silber, J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (04) : S78 - S78